Analysts/Institutional Investor Meet/Con. Call Updates

Windlas Biotech Limited Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199 Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030 CIN-L74899UR2001PLC033407 November 06, 2026 To To Listing / Compliance Department Listing / Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai – 400 001 Bandra Kurla Complex Bandra (E), Mumbai – 400 051 BSE CODE: 543329 NSE SYMBOL: WINDLAS Dear Sir/ Madam, Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Recording of Conference Call In continuation to our letter dated October 30, 2026, regarding intimation of Investors/ Analyst conference call on the unaudited standalone financial results of the Company for the quarter and half year ended September 30, 2026, we would like to inform you that the audio recording of the said call has been uploaded on the Company’s website. This can be accessed via the following link. Link: https://windlas.com/audio-transcript/ The transcript for the said call will be shared with the Stock Exchanges and will also be uploaded on the Company’s website (https://windlas.com) in due course. This is for your information and record. Thanking you, Yours faithfully, For Windlas Biotech Limited Ananta Narayan Panda Company Secretary & Compliance Officer www.windlas.com